Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells

A simple method for attaching immunoglobulin G (IgG) on the cell surface was successfully developed for enhancing phagocytosis of apoptotic tumor cells (ATCs) by dendritic cells (DCs) <em>ex vivo</em>. By conjugating with a poly(ethylene glycol) (PEG)-lipid, named the bio...

Full description

Bibliographic Details
Main Authors: Teruyuki Nagamune, Satoshi Takamori, Satoshi Yamaguchi, Yoichiro Sugimoto, Urara Tomita
Format: Article
Language:English
Published: MDPI AG 2012-04-01
Series:Pharmaceuticals
Subjects:
Online Access:http://www.mdpi.com/1424-8247/5/5/405
_version_ 1818559771382382592
author Teruyuki Nagamune
Satoshi Takamori
Satoshi Yamaguchi
Yoichiro Sugimoto
Urara Tomita
author_facet Teruyuki Nagamune
Satoshi Takamori
Satoshi Yamaguchi
Yoichiro Sugimoto
Urara Tomita
author_sort Teruyuki Nagamune
collection DOAJ
description A simple method for attaching immunoglobulin G (IgG) on the cell surface was successfully developed for enhancing phagocytosis of apoptotic tumor cells (ATCs) by dendritic cells (DCs) <em>ex vivo</em>. By conjugating with a poly(ethylene glycol) (PEG)-lipid, named the biocompatible anchor for the membrane (BAM), arbitrary IgG could be incorporated into the cell membrane. In particular, when IgG-BAM conjugates were prepared at the optimal molar ratio of IgG to BAM (1 to 20), almost all cells were efficiently modified with IgG by treatment with IgG-BAM. This simple method was successfully applied to four types of mammalian cells. Furthermore, treatment of ATCs with the IgG-BAM conjugate increased the phagocytosis ratio of ATCs by DCs two-fold when compared to no treatment. This phagocytosis-enhancing effect was nearly identical to treatment with a tumor-specific IgG. Thus, without employing the tumor-specific IgG, which is difficult to obtain for any tumor cells and is expensive, the present method could opsonize ATC with the use of arbitrary IgG. The results strongly indicate that IgG-BAM treatment represents a promising method for opsonizing ATC with human serum IgG, and that this approach will lead to objective clinical responses in DC vaccines.
first_indexed 2024-12-14T00:29:52Z
format Article
id doaj.art-5044990bbd734e739591722ff2e8a24b
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-12-14T00:29:52Z
publishDate 2012-04-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-5044990bbd734e739591722ff2e8a24b2022-12-21T23:24:53ZengMDPI AGPharmaceuticals1424-82472012-04-015540541610.3390/ph5050405Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer CellsTeruyuki NagamuneSatoshi TakamoriSatoshi YamaguchiYoichiro SugimotoUrara TomitaA simple method for attaching immunoglobulin G (IgG) on the cell surface was successfully developed for enhancing phagocytosis of apoptotic tumor cells (ATCs) by dendritic cells (DCs) <em>ex vivo</em>. By conjugating with a poly(ethylene glycol) (PEG)-lipid, named the biocompatible anchor for the membrane (BAM), arbitrary IgG could be incorporated into the cell membrane. In particular, when IgG-BAM conjugates were prepared at the optimal molar ratio of IgG to BAM (1 to 20), almost all cells were efficiently modified with IgG by treatment with IgG-BAM. This simple method was successfully applied to four types of mammalian cells. Furthermore, treatment of ATCs with the IgG-BAM conjugate increased the phagocytosis ratio of ATCs by DCs two-fold when compared to no treatment. This phagocytosis-enhancing effect was nearly identical to treatment with a tumor-specific IgG. Thus, without employing the tumor-specific IgG, which is difficult to obtain for any tumor cells and is expensive, the present method could opsonize ATC with the use of arbitrary IgG. The results strongly indicate that IgG-BAM treatment represents a promising method for opsonizing ATC with human serum IgG, and that this approach will lead to objective clinical responses in DC vaccines.http://www.mdpi.com/1424-8247/5/5/405antibody conjugatesdendritic cell vaccineantibody-dependent cell phagocytosispoly(ethylene glycol)-lipid
spellingShingle Teruyuki Nagamune
Satoshi Takamori
Satoshi Yamaguchi
Yoichiro Sugimoto
Urara Tomita
Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells
Pharmaceuticals
antibody conjugates
dendritic cell vaccine
antibody-dependent cell phagocytosis
poly(ethylene glycol)-lipid
title Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells
title_full Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells
title_fullStr Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells
title_full_unstemmed Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells
title_short Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells
title_sort poly ethylene glycol lipid conjugated antibodies enhance dendritic cell phagocytosis of apoptotic cancer cells
topic antibody conjugates
dendritic cell vaccine
antibody-dependent cell phagocytosis
poly(ethylene glycol)-lipid
url http://www.mdpi.com/1424-8247/5/5/405
work_keys_str_mv AT teruyukinagamune polyethyleneglycollipidconjugatedantibodiesenhancedendriticcellphagocytosisofapoptoticcancercells
AT satoshitakamori polyethyleneglycollipidconjugatedantibodiesenhancedendriticcellphagocytosisofapoptoticcancercells
AT satoshiyamaguchi polyethyleneglycollipidconjugatedantibodiesenhancedendriticcellphagocytosisofapoptoticcancercells
AT yoichirosugimoto polyethyleneglycollipidconjugatedantibodiesenhancedendriticcellphagocytosisofapoptoticcancercells
AT uraratomita polyethyleneglycollipidconjugatedantibodiesenhancedendriticcellphagocytosisofapoptoticcancercells